Stockreport

US$16.50 - That's What Analysts Think Pulmonx Corporation (NASDAQ:LUNG) Is Worth After These Results [Yahoo! Finance]

Pulmonx Corporation  (LUNG) 
US:NASDAQ Investor Relations: investor.prolunginc.com/investor-relations
PDF Revenue hit US$69m in line with forecasts, although the company reported a statutory loss per share of US$1.60 that was somewhat smaller than the analysts expected. The [Read more]